StemMedical A/S
CVR number: 35852808
Gyngemose Parkvej 50, 2860 Søborg
info@stemform.com
tel: 40891243
www.stemform.com
Income statement (kDKK)
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -1 538.84 | -2 061.69 | -3 792.95 | -4 371.01 | -7 902.53 |
| Employee benefit expenses | - 591.56 | -2 397.57 | -3 719.21 | -8 822.45 | -11 156.87 |
| Total depreciation | - 896.92 | -1 541.06 | -1 108.13 | -1 265.17 | -1 159.70 |
| EBIT | -3 027.32 | -6 000.32 | -8 620.29 | -14 458.64 | -20 219.09 |
| Other financial expenses | -75.59 | -56.84 | -92.50 | -88.07 | -99.35 |
| Pre-tax profit | -3 102.91 | -6 057.16 | -8 712.79 | -14 546.71 | -20 318.45 |
| Income taxes | 713.10 | 1 974.04 | 976.22 | 1 325.35 | 1 442.39 |
| Net earnings | -2 389.80 | -4 083.12 | -7 736.57 | -13 221.37 | -18 876.06 |
Assets (kDKK)
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Development expenditure | 600.00 | ||||
| Intangible rights | 890.49 | 1 082.28 | 1 212.40 | 1 219.65 | 1 256.49 |
| Intangible assets total | 1 490.49 | 1 082.28 | 1 212.40 | 1 219.65 | 1 256.49 |
| Buildings | 189.04 | 94.24 | 44.10 | 403.07 | 1 161.57 |
| Machinery and equipment | 2 806.34 | 2 150.91 | 1 960.79 | 2 171.61 | 1 703.26 |
| Tangible assets total | 2 995.39 | 2 245.16 | 2 004.89 | 2 574.67 | 2 864.83 |
| Other receivables | 27.54 | 27.54 | 95.34 | 180.94 | 180.94 |
| Investments total | 27.54 | 27.54 | 95.34 | 180.94 | 180.94 |
| Long term receivables total | |||||
| Finished products/goods | 269.72 | 941.04 | 1 852.26 | ||
| Inventories total | 269.72 | 941.04 | 1 852.26 | ||
| Current other receivables | 803.40 | 82.72 | 528.22 | 867.23 | 164.06 |
| Current deferred tax assets | 713.10 | 2 687.14 | 976.22 | 1 325.35 | 1 442.39 |
| Short term receivables total | 1 516.50 | 2 769.86 | 1 504.44 | 2 192.58 | 1 606.45 |
| Cash and bank deposits | 2 691.40 | 1 475.06 | 26 061.87 | 11 108.05 | 5 530.63 |
| Cash and cash equivalents | 2 691.40 | 1 475.06 | 26 061.87 | 11 108.05 | 5 530.63 |
| Balance sheet total (assets) | 8 721.33 | 7 599.90 | 31 148.66 | 18 216.93 | 13 291.61 |
Equity and liabilities (kDKK)
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Share capital | 514.65 | 525.97 | 595.29 | 595.29 | 623.74 |
| Share premium account | 4 354.64 | ||||
| Retained earnings | 3 785.56 | 9 103.26 | 36 747.76 | 29 011.20 | 30 645.18 |
| Profit of the financial year | -2 389.80 | -4 083.12 | -7 736.57 | -13 221.37 | -18 876.06 |
| Shareholders equity total | 6 265.04 | 5 546.11 | 29 606.49 | 16 385.12 | 12 392.86 |
| Non-current leasing loans | 822.24 | 167.57 | |||
| Non-current other liabilities | 87.93 | ||||
| Non-current liabilities total | 822.24 | 255.50 | |||
| Current trade creditors | 126.92 | 511.71 | 577.60 | 968.44 | 180.40 |
| Other non-interest bearing current liabilities | 862.78 | 975.87 | 902.43 | 863.38 | 718.35 |
| Accruals and deferred income | 644.35 | 310.71 | 62.14 | ||
| Current liabilities total | 1 634.05 | 1 798.29 | 1 542.17 | 1 831.81 | 898.74 |
| Balance sheet total (liabilities) | 8 721.33 | 7 599.90 | 31 148.66 | 18 216.93 | 13 291.61 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.